Future scenarios for the prevention and delay of alzheimer disease onset in high-risk groups:: An ethical perspective
- 28 February 1999
- journal article
- review article
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 16 (2) , 105-110
- https://doi.org/10.1016/s0749-3797(98)00139-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's diseaseNeurology, 1998
- A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for DementiaJAMA, 1997
- A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's DiseaseNew England Journal of Medicine, 1997
- Drug treatments for Alzheimer's diseaseBMJ, 1997
- Religiosity and Perceived Rewards of Black and White CaregiversThe Gerontologist, 1997
- The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled TrialDementia and Geriatric Cognitive Disorders, 1996
- Senile dementia in Japan: Prevalence and responseSocial Science & Medicine, 1996
- The Economic Burden of Alzheimer's Disease CareHealth Affairs, 1993
- Estimated Prevalence of Alzheimer's Disease in the United StatesThe Milbank Quarterly, 1990
- Prevalence of Alzheimer's Disease in a Community Population of Older PersonsJAMA, 1989